Name

Dynamiker

Legal name

丹娜(天津)生物科技股份有限公司

Website

https://dynamiker.com

Company type

Public

Founded year

2014

Operating status

Operating

Headcount range

1–10 employees

Ownership category

akta.pro rank

Product category

In Vitro Diagnostics (IVD) for Invasive Fungal Disease

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413), Analytical Laboratory Instrument Manufacturing (334516)

SIC

In Vitro & In Vivo Diagnostic Substances (2835), Laboratory Analytical Instruments (3826)

akta.pro primary industry

IVD Reagents, Assay Kits & Consumables (Non-instrument) (HLAHAAAM)

akta.pro secondary industries

Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes) (HLAGAIAI), Microbiology & Infectious Disease Diagnostics (Culture/ID/AST) (HLAHAAAC)

Keywords

• Invasive fungal diagnostics
• In vitro diagnostic reagents
• Chemiluminescence immunoassay
• Molecular PCR diagnostics
• Industrial endotoxin testing

Headquarters

HQ city

Tianjin

HQ country

China

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Supply Chain, Marketing or Sales, Personnel, Operations

Revenue model

1. IVD Reagent Kits: Sale of diagnostic reagent kits for invasive fungal disease detection including G test, GM test, Aspergillus IgG antibody, Candida mannan antigen/antibody, Cryptococcal antigen, inflammatory markers (PCT, CRP, IL-6, SAA), COVID-19 antibodies, and bacterial drug resistance testing kits. One-time purchase model per kit with varying yields per box (e.g., 50/100/200 tests per box).
2. Diagnostic Instruments: Sale and distribution of automated diagnostic instruments including Funguy D240 automated endotoxin/glucan detector, FIC-Q100N dry fluorescence immunoassay analyzer, Venus 100S automated chemiluminescence analyzer, and DNK-A200/A600 automated microplate readers.
3. Industrial Endotoxin Products: Sale of industrial endotoxin testing products including LAL reagent (gel method, dynamic chromogenic method), bacterial endotoxin standard (CSE), endotoxin indicator (ECV), and endotoxin-free water for pharmaceutical quality control testing.

Pricing tiers

Go-to-market motion1 record

Distribution channels5 records

Marketing channels6 records

Core offering

Dynamiker develops, manufactures, and globally sells in vitro diagnostic (IVD) reagent kits, automated instruments, and industrial endotoxin testing products for the detection of invasive fungal disease (IFD) and other pathogenic microorganisms. Its 5G+ combined fungal serology scheme (G test, GM test, Aspergillus IgG, Candida mannan antigen/antibody, Cryptococcal antigen) is supported across chemiluminescence, POCT, ELISA, and fluorescent PCR platforms. The company also supplies inflammation biomarker kits (PCT, CRP, IL-6, SAA), carbapenemase antibiotic resistance tests, and LAL-based endotoxin reagents for pharmaceutical quality control.

Product overview

Dynamiker (丹娜生物) is a high-tech biopharmaceutical company founded in 2014, specializing in the R&D, manufacturing, and global sales of innovative in vitro diagnostic products for invasive fungal disease (IFD) and other pathogenic microorganisms. The company operates a multi-platform diagnostic portfolio organized into: (1) fungal serology assays (5G+ combined detection scheme — G test, GM test, Aspergillus IgG, Candida mannan/IgG, Cryptococcal antigen), (2) inflammation biomarker assays (procalcitonin, C-reactive protein, IL-6, serum amyloid A), (3) antibiotic resistance detection (carbapenemase), (4) industrial endotoxin testing (LAL reagents, endotoxin standards), and (5) supporting instruments (Funguy D240, FIC-Q100N, automated endotoxin platform). The products span multiple detection modalities — enzyme kinetics, ELISA, chemiluminescence, POCT immunochromatography, and molecular PCR — enabling comprehensive coverage from screening to species-level identification across clinical and industrial applications.

Differentiator

Problem solved

Functional benefit

Products and services

• Fungal (1-3)-β-D Glucan Detection Kit (G Test) Series Detection reagents for (1-3)-β-D-glucan, a pan-fungal biomarker, available in multiple methodological formats for invasive fungal disease screening in hospital clinical microbiology laboratories, ICUs, hematology/oncology departments, and transplant centers.
• Aspergillus Galactomannan Detection Kit (GM Test) Series Aspergillus galactomannan antigen detection reagents available in ELISA, fluorescent immunochromatographic, and chemiluminescence formats for diagnosing invasive aspergillosis in hospital clinical microbiology labs and infectious disease departments.
• Cryptococcal Capsular Polysaccharide Antigen Detection Kit Cryptococcal capsular polysaccharide antigen detection reagents in colloidal gold (POCT) and chemiluminescence formats for diagnosing cryptococcal meningitis and cryptococcal infection in hospital laboratories.
• Candida Mannan Antigen and IgG Antibody Detection Kit Candida mannan antigen and IgG antibody detection reagents in ELISA and chemiluminescence formats for diagnosing invasive candidiasis in clinical microbiology laboratories and infectious disease departments.
• Aspergillus IgG Antibody Detection Kit Aspergillus IgG antibody detection reagents for diagnosing chronic pulmonary aspergillosis and Aspergillus-related infections, in ELISA, fluorescent immunochromatographic, and chemiluminescence formats.
• Aspergillus Nucleic Acid Detection Kit (Fluorescent PCR) Aspergillus nucleic acid detection kit using fluorescent PCR method for species-level identification of Aspergillus from clinical samples including BALF (bronchoalveolar lavage fluid), enabling hour-level precise diagnosis.
• Procalcitonin Quantitative Detection Kit (PCT) Procalcitonin quantitative detection reagent using magnetic particle chemiluminescence for sepsis diagnosis and inflammatory condition monitoring in hospital clinical laboratories and ICUs.
• C-Reactive Protein Detection Kit (CRP) C-reactive protein (CRP) detection reagents including full-range CRP and conventional CRP in magnetic particle chemiluminescence format for inflammation assessment in clinical laboratories.
• Interleukin-6 Detection Kit (IL-6) Interleukin-6 quantitative detection reagent using magnetic particle chemiluminescence for inflammatory cytokine monitoring in hospital clinical settings.
• Serum Amyloid A Protein Detection Kit (SAA) Serum amyloid A protein quantitative detection reagent using magnetic particle chemiluminescence for inflammation and infection assessment.
• Gram-Negative Bacterial Lipopolysaccharide Detection Kit Gram-negative bacterial lipopolysaccharide (endotoxin) detection reagents in colorimetric and photometric formats for bacterial infection diagnosis in clinical laboratories.
• Bacterial Endotoxin Detection Kit (Clinical) Bacterial endotoxin detection reagents in dynamic turbidimetric and dynamic chromogenic formats for pharmaceutical quality control and clinical applications.
• Limulus Amebocyte Lysate (LAL) Reagent for Industrial Endotoxin Testing Limulus amebocyte lysate (LAL) reagents in gel-clot and dynamic chromogenic formats plus CSE standards, ECV indicators, and endotoxin-free water for endotoxin detection in pharmaceutical and medical device manufacturing quality control.
• Carbapenemase Detection Kit (Colloidal Gold) Carbapenemase detection reagent using colloidal gold method for identifying five carbapenemase genotypes (KPC/NDM/IMP/OXA-48/VIM) to support antibiotic resistance monitoring in hospital clinical microbiology laboratories.
• Automated Endotoxin Detection Platform Automated endotoxin detection instrument that completes sample dilution, positive sample preparation, reagent reconstitution, dispensing, and reading automatically with 21 specimen positions, 5-level dilution up to 20,000x, and 21 CFR Part 11 compliance.
• Funguy D240 Automated Endotoxin / Fungal Glucan Detector Automated benchtop instrument for simultaneous detection of bacterial endotoxin and fungal (1-3)-β-D-glucan, with temperature-controlled reaction chambers at 36±0.5°C and automated sample processing for clinical laboratories.
• FIC-Q100N Dry Fluorescence Immunoassay Analyzer Point-of-care dry fluorescence immunoassay analyzer for quantitative detection using fluorescence-labeled immunochromatographic reagents, with a 5-year detection shelf life for near-patient and bedside testing.
• 5G+ Combined Fungal Serology Detection Scheme Comprehensive combined detection scheme integrating G test, GM test, Aspergillus IgG antibody, Candida mannan, Candida IgG antibody, and Cryptococcal antigen tests across chemiluminescence, POCT immunochromatographic, and automated ELISA platforms, covering major invasive fungal disease types.

Quantifiable outcome

• G test (1-3-β-D-glucan) can deliver results in hours vs. days for culture-based methods, reducing time-to-diagnosis significantly for invasive fungal infections
• +1 more outcomes

Named customers8 records

Segments3 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration7 records

AI capability3 records

Feature5 records

Partnerships

Six partnerships are on record, tiered core and minor.

• Tianjin Laboratory Medicine Society (天津市检验医学学会)coreStrategic or Co-development Partner · 1 May 2026Tianjin Laboratory Medicine Society President Liu Shuye and Vice President Liu Yunyun visited Dynamiker in May 2026. Discussions focused on talent cultivation, technology innovation, achievement transformation, and new track development. The Society will leverage its expert think-tank advantages while Dynamiker provides its industry practice platform, jointly building an integrated innovation ecosystem of 'industry-academia-research-application'. This partnership aligns the Society's academic platform and expert resources with Dynamiker's industrialization and technology innovation capabilities.
• Weigao Shengji Medical Industry Group (威高生基医疗产业集团)coreStrategic or Co-development Partner · 26 March 2026On March 26, 2026, Dynamiker and Weigao Shengji signed a strategic cooperation agreement in Weihai, Shandong. Weigao Shengji has nationwide hospital channel coverage, centralized services capability, and centralized procurement (集采) listing advantages. Dynamiker brings core technology in fungal disease diagnosis, complete product registration system, and clear clinical刚需 scenarios. The partnership aims for product integration, channel collaboration, and joint technology R&D in microbial diagnostic solutions. The two companies have highly complementary resources and capabilities in the context of domestic substitution (国产替代) opportunities.
• Nankai University (南开大学)coreStrategic or Co-development Partner · 15 January 2026Nankai University Vice President Fang Yongchun led a delegation to Dynamiker on January 15, 2026. Discussions covered deepening university-enterprise cooperation, accelerating technology transfer, and innovative talent cultivation. Key collaboration areas identified include: (1) joint research with the National Key Laboratory of Medicinal Chemical Biology on drug R&D and chemical-biological synthesis; (2) establishing a regular cooperation platform with School of Pharmacy, Chemistry, Life Sciences, and AI College; (3) joint talent cultivation programs. Both parties agreed to build a comprehensive strategic partnership.
• Peking Union Medical College Hospital / Chinese Academy of Medical Sciences (中国医学科学院北京协和医院)coreStrategic or Co-development Partner · 1 January 2026Dynamiker is the core participating unit in a 2026 National Science and Technology Major Special Project led by PUMCH — 'Precision Diagnosis, Treatment and Prevention Strategy Research for Important Pathogenic Fungi Based on Reference Laboratory System' (Project No. 2026ZD01909600). Dynamiker contributes its expertise in rapid detection of invasive fungal diseases and drug resistance identification, supporting the construction of a national pathogenic fungi reference laboratory quality control system, standard strain resource bank, and clinical rapid testing technologies.
• CCTV (Central Television of China)minorGTM or Marketing Partner · 1 September 2025Dynamiker was featured in CCTV's documentary series 'Innovation Journey' (创新的征途), specifically Episode 5 '守护生命' (Protecting Life), broadcast on September 3, 2025. The documentary showcased Dynamiker as China's pioneer in invasive fungal disease early diagnosis technology, reaching a national audience and building brand awareness through earned media coverage.
• Tianjin University of Science and Technology (天津科技大学)coreStrategic or Co-development Partner · 1 May 2023Dynamiker and Tianjin University of Science and Technology co-built a Biomedical Modern Industry College (生物医药现代产业学院), conducting regular teaching seminars. This partnership focuses on talent cultivation, curriculum development, and industry-academia-research collaboration in biomedical engineering and related fields.

Scale indicators8 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• ELITech Group: European IVD company offering fungal diagnostic kits (beta-glucan, galactomannan, cryptococcal antigen), historically a direct competitor in clinical microbiology labs across European and emerging markets.
• IMMY (acquired by Bio-Rad): Specialist in Cryptococcal antigen lateral flow diagnostics (CrAg LFA), directly comparable to Dynamiker's Cryptococcal capsular polysaccharide detection reagents in both POCT and chemiluminescence formats.
• FUJIFILM Wako: Japanese IVD player offering beta-glucan (Glucatell) and endotoxin testing kits, directly comparable to Dynamiker's G test, endotoxin reagents, and Funguy D240 instrument.
• Zhuhai Livzon Diagnostics: Chinese IVD player with a beta-glucan (G test) kit directly comparable to Dynamiker's core fungal screening product, competing in the same Chinese hospital microbiology market.
• Associates of Cape Cod (part of Pacific Bio): Specialized manufacturer of LAL endotoxin reagents (Pyrochrome, Kinetic-QCL) for pharmaceutical QC, directly comparable to Dynamiker's industrial endotoxin product line and 21 CFR Part 11-compliant automated platform.
• Bio-Rad Laboratories: Global IVD leader with the Platelia Aspergillus EIA (GM test), Pastorex Crypto, and beta-glucan assays — the most direct global competitor to Dynamiker's fungal serology portfolio in hospitals and reference labs.

Broad incumbents

• Autobio Diagnostics: Major Chinese IVD company with broad chemiluminescence and ELISA menu serving clinical microbiology labs; relevant comparable for Dynamiker's domestic commercialization, scale, and competitive context in China.
• Snibe (Shenzhen New Industries Biomedical Engineering): Leading Chinese chemiluminescence immunoassay platform provider with a broad infectious-disease and inflammation menu; directly comparable to Dynamiker's Venus 100S chemiluminescence franchise and broader commercial model.
• bioMérieux: Global microbiology and infectious disease diagnostics leader with broad clinical-microbiology portfolio, including VITEK and BioBall fungal ID/AST; competes with Dynamiker in the broader microbiology lab budget allocation.
• Bruker: Provides MALDI-TOF (MBT) fungal identification systems and broader microbiology mass spectrometry; competes with Dynamiker's molecular Aspergillus PCR via a different but adjacent fungal-identification technology.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/dynamiker

Compliance8 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Dynamiker